A case of Anti-MDA5-Positive dermatomyositis after inactivated COVID-19 vaccine
- PMID: 36222733
- PMCID: PMC9874769
- DOI: 10.1111/jdv.18653
A case of Anti-MDA5-Positive dermatomyositis after inactivated COVID-19 vaccine
Conflict of interest statement
The first author is the wife of the patient, the other authors have no potential conflicts of interest to disclose.
Figures
References
-
- Carrasco L, Arthur A, Gaitan RJ, Case C. A rapidly progressive and rare illness: autoantibodies against melanoma diferentiation‐associated protein 5 (anti‐MDA5): amyopathic dermatomyositis with progressive interstitial lung disease that developed after covid‐19 vaccine. Chest J. 2021;160(4):A680–1.
-
- Lundberg IE, Tjarnlund A, Bottai M, Werth VP, Pilkington C, de Visser M, et al. 2017 European league against rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017;76(12):1955–64. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 81303139/Data Center of Management Science, National Natural Science Foundation of China - Peking University
- 82103726/Data Center of Management Science, National Natural Science Foundation of China - Peking University
- SZXJ2017046/Project of Shenzhen Municipal Health Commission
- SZXK040/Shenzhen Key Medical Discipline Construction Fund
- SZSM201812059/Shenzhen Sanming Project
LinkOut - more resources
Full Text Sources
Medical
